Literature DB >> 23811304

Possible involvement of CCL1-CCR8 interaction in lymphocytic recruitment in IgG4-related sclerosing cholangitis.

Yoh Zen1, Rodrigo Liberal, Yasuni Nakanuma, Nigel Heaton, Bernard Portmann.   

Abstract

BACKGROUND & AIMS: IgG4-related sclerosing cholangitis and type 1 autoimmune pancreatitis (IgG4-SC/AIP) are characterized by massive lymphoplasmacytic infiltration including Th2 and regulatory T cells (Tregs). This study was conducted to address which chemotactic factors are involved in this condition.
METHODS: Chemokine expression profiles in tissue were examined in IgG4-SC/AIP (n=17), classical primary sclerosing cholangitis (IgG4(low) PSC, n=17), PSC with elevated serum/tissue IgG4 levels (IgG4(high) PSC, n=5), and primary biliary cirrhosis (n=7). We focused on five chemotactic factors/receptors (CCL1-CCR8, CCL17/CCL22-CCR4), given that CCR4 and CCR8 are predominantly expressed in both Th2 and Tregs.
RESULTS: In conjunction with higher expression levels of IL-4 and IL-10, expression values of CCL1 and CCR8 transcripts were significantly higher in IgG4-SC/AIP than in IgG4(low) PSC (p=0.002) and IgG4(high) PSC (p=0.023). CCL1 and CCR8 were also overexpressed in IgG4(high) PSC than in IgG4(low) PSC (p=0.023). No difference was seen for CCL17, CCL22, and CCR4. In situ hybridization revealed CCL1 to be predominantly expressed in the pancreatic duct epithelium, peribiliary glands, and vascular endothelial cells including the ones involved in obliterative phlebitis in IgG4-SC/AIP, in contrast to IgG4(high) PSC where this chemotactic factor was positive in several infiltrating lymphocytes. These CCL1-expressing sites were infiltrated by CCR8(+) lymphocytes. On immunohistochemistry, GATA3(+) Th2 lymphocytes and FOXP3(+) Tregs were significantly larger in number in IgG4-SC/AIP, with the GATA3(+)/T-bet(+) cell ratio to be shifted in favour of Th2 in periductal and perivascular areas.
CONCLUSIONS: CCL1-CCR8 interaction may play a critical role in lymphocytic recruitment in IgG4-SC/AIP, leading to duct-centred inflammation and obliterative phlebitis.
Copyright © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoimmune pancreatitis; Chemokine; Cytokine; IgG4; IgG4(high) PSC; IgG4(low) PSC; IgG4-SC/AIP; IgG4-related sclerosing cholangitis and type 1 autoimmune pancreatitis; Obliterative phlebitis; PBC; PSC; Primary sclerosing cholangitis; Regulatory T cell; Th2; Treg; high-power field; hpf; primary biliary cirrhosis; primary sclerosing cholangitis; primary sclerosing cholangitis with elevated IgG4; primary sclerosing cholangitis with normal IgG4; regulatory T cell

Mesh:

Substances:

Year:  2013        PMID: 23811304     DOI: 10.1016/j.jhep.2013.06.016

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  17 in total

1.  Expression of the chemokine receptor gene, CCR8, is associated With DUSP22 rearrangements in anaplastic large cell lymphoma.

Authors:  Xiaoming Xing; Thomas J Flotte; Mark E Law; Anthony J Blahnik; Wee-Joo Chng; Gaofeng Huang; Ryan A Knudson; Rhett P Ketterling; Julie C Porcher; Stephen M Ansell; Jagmohan Sidhu; Ahmet Dogan; Andrew L Feldman
Journal:  Appl Immunohistochem Mol Morphol       Date:  2015-09

2.  Sox2 Communicates with Tregs Through CCL1 to Promote the Stemness Property of Breast Cancer Cells.

Authors:  Yingxi Xu; Xiaoli Dong; Pingping Qi; Yujie Ye; Wenzhi Shen; Liang Leng; Lina Wang; Xuefei Li; Xiaohe Luo; Yanan Chen; Peiqing Sun; Rong Xiang; Na Li
Journal:  Stem Cells       Date:  2017-12       Impact factor: 6.277

Review 3.  IgG4-related diseases of the digestive tract.

Authors:  J-Matthias Löhr; Miroslav Vujasinovic; Jonas Rosendahl; John H Stone; Ulrich Beuers
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-11-08       Impact factor: 46.802

4.  A high number of IgG4-positive cells in gastric cancer tissue is associated with tumor progression and poor prognosis.

Authors:  Kozo Miyatani; Hiroaki Saito; Yuki Murakami; Joji Watanabe; Hirohiko Kuroda; Tomoyuki Matsunaga; Yoji Fukumoto; Tomohiro Osaki; Yuji Nakayama; Yoshihisa Umekita; Masahide Ikeguchi
Journal:  Virchows Arch       Date:  2016-03-07       Impact factor: 4.064

Review 5.  IgG4-related hepatobiliary disease: an overview.

Authors:  Emma L Culver; Roger W Chapman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-14       Impact factor: 46.802

Review 6.  IgG4-related sclerosing cholangitis: all we need to know.

Authors:  Yoh Zen; Hiroshi Kawakami; Jung Hoon Kim
Journal:  J Gastroenterol       Date:  2016-01-27       Impact factor: 7.527

7.  Bovine Lactoferrin-Induced CCL1 Expression Involves Distinct Receptors in Monocyte-Derived Dendritic Cells and Their Monocyte Precursors.

Authors:  Daniela Latorre; Nadia Pulvirenti; Daniela Angela Covino; Barbara Varano; Cristina Purificato; Gabriella Rainaldi; Maria Cristina Gauzzi; Laura Fantuzzi; Lucia Conti; Gloria Donninelli; Manuela Del Cornò; Michela Sabbatucci; Sandra Gessani; Patrizia Puddu
Journal:  Toxins (Basel)       Date:  2015-12-17       Impact factor: 4.546

8.  T Cell Polarization toward TH2/TFH2 and TH17/TFH17 in Patients with IgG4-Related Disease.

Authors:  Aurélie Grados; Mikael Ebbo; Christelle Piperoglou; Matthieu Groh; Alexis Regent; Maxime Samson; Benjamin Terrier; Anderson Loundou; Nathalie Morel; Sylvain Audia; François Maurier; Julie Graveleau; Mohamed Hamidou; Amandine Forestier; Sylvain Palat; Emmanuelle Bernit; Bernard Bonotte; Catherine Farnarier; Jean-Robert Harlé; Nathalie Costedoat-Chalumeau; Frédéric Vély; Nicolas Schleinitz
Journal:  Front Immunol       Date:  2017-03-13       Impact factor: 7.561

Review 9.  Review of primary sclerosing cholangitis with increased IgG4 levels.

Authors:  Charis D Manganis; Roger W Chapman; Emma L Culver
Journal:  World J Gastroenterol       Date:  2020-06-21       Impact factor: 5.742

10.  Cellular crosstalk during cholestatic liver injury.

Authors:  Joanne Thomson; Laura Hargrove; Lindsey Kennedy; Jennifer Demieville; Heather Francis
Journal:  Liver Res       Date:  2017-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.